Fortem Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Fortem Financial Group's GILD Position: Q2 2026 in Review
Fortem Financial Group increased its Gilead Sciences (GILD) stake by 3.5% in Q2 2026, buying an estimated $29.1K and bringing the position to 6,585 shares worth $832K. The position accounts for 0.17% of the portfolio, ranked #98.
Fortem Financial Group first reported a position in GILD in Q4 2020 and has held it in 18 quarters since. The position peaked at $887K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Fortem Financial Group held 6,585 shares of Gilead Sciences worth $832K as of Q2 2026.
- Fortem Financial Group bought 221 Gilead Sciences shares in Q2 2026, an estimated $29.1K.
- Gilead Sciences made up 0.17% of Fortem Financial Group's portfolio in Q2 2026, its #98 holding.
- Fortem Financial Group first reported a position in Gilead Sciences in Q4 2020 and has held it in 18 quarters since.
- Fortem Financial Group's Gilead Sciences position peaked at $887K in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Fortem Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.